Sex differences in dopamine receptor overproduction and elimination

NeuroReport

Volumn 8, Issue 6, 1997, Pages 1495-1498

  Andersen, Susan L ^a   Rutstein, Mark ^a,b   Benzo, José M ^a   Hostetter, John C ^a,c   Teicher, Martin H ^a  

^a MCLEAN HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Adolescence; Attention deficit hyperactivity disorder; D1; D2; Development; Dopamine overproduction; Pruning; Sex differences; Tourette's syndrome

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR;

ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; AUTORADIOGRAPHY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; FEMALE; GILLES DE LA TOURETTE SYNDROME; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREVALENCE; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEX DIFFERENCE;

EID: 0030917276     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199704140-00034     Document Type: Article

References (25)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn., 1994:182-272.
2. Babigian HM. Comprehensive Textbook of Psychiatry/III. Baltimore: Williams & Wilkins, 1980:1115-1117.
3. Goodwin FW and Jamison KR. Manic Depressive Illness. New York: Oxford Press, 1990:157-185.
4. Weissman MM and Klermann GL. Arch Gen Psychiatry 34, 98-111 (1977).
5. Swab DF and Fliers E. Science 228, 1112-1115 (1985).
6. Allen LS, Hines M, Shryne JE et al. J Neurosci 9, 497-506 (1989).
7. Shaywitz BA, Shaywitz SE, Pugh KR et al. Nature 373, 607-609 (1995).
8. Gur RC, Mozley LH, Mozley PD et al. Science 267, 528-531 (1995).
9. Huttenlocher PR. Brain Res 163, 195-205 (1979).
10. Lidow MS, Goldman-Rakic PS and Rakic P. Proc Natl Acad Sci USA 88, 10218-10221 (1991).
11. Seeman P, Bzowej N, Guan H et al. Synapse 1, 399-404 (1987).
12. Teicher MH, Andersen SL and Hostetter JC. Dev Brain Res 89, 167-172 (1995).
13. Wolf SS, Jones DW, Knable MB et al. Science 273, 1225-1227 (1996).
14. Castellanos FX, Giedd JN, Marsh WL et al. Arch Gen Psychiatry 53, 607-616 (1996).
15. Lou HC, Henriksen L, Bruhn P et al. Arch Neurol 46, 48-52 (1990).
16. Maldonado R, Robledo P, Chover AJ et al. Pharmacol Biochem Behav 45, 239-242 (1993).
17. Seeman P, Guan HC and VanTol HHM. Nature 365, 441-445 (1993).
18. Munson P and Rodbard D. Anal Biochem 107, 220-239 (1980).
19. Reisner AH, Nemes P and Bucholtz C. Anal Biochem 64, 509-512 (1975).
20. Gelbard HA, Teicher MH, Faedda G et al. Dev Brain Res 49, 123-130 (1989).
21. Ferretti C, Blengio M, Vigna I et al. Brain Res 571, 212-217 (1992).
22. Giedd JN, Snell JW, Lange N et al. Cerebral Cortex 6, 551-560 (1996).
23. Giros M, Jaber M, Jones SR et al. Nature 379, 606-612 (1996).
24. Niemegeers CJE and Janssen PA. Arzneim Forsch 24, 45-52 (1974).
25. Earnst M, Liebenauer LL, King C et al. J Am Acad Child Adolesc Psychiatry 33, 858-868 (1994).